4th Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Period 4th Quarter 2012 Filed Jan 22, 2013 Signed by Mark E. Cooke, Sr. Director Government Affairs

Official filing
Firm
PHARMATHENE, INC
Client
PHARMATHENE, INC
Income
—
Expenses
$73,273
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy for Pandemic and All-Hazards Preparedness Reauthorization Act 2012 (PAHPRA) in U.S. House (HR 2405) and U.S. Senate (S.1855). Encourage continued funding for the Biodefense Advanced Research and Development Authority (BARDA) at HHS with the House Labor-HHS Appropriations Subcommittee and Senate HELP and Labor-HHS Appropriations Committee. Continued education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. VP Policy and Government Affairs
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 1855 (112th), H.R. 2405 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.